Chacon Quiros Juan Jose 4

What Happened

• Juan Jose Chacon Quiros, a director of Establishment Labs Holdings, sold a total of 75,000 common shares in open-market transactions between April 23 and April 27, 2026, generating approximately $4,919,478 in proceeds.
• Trades were executed at reported weighted-average prices between roughly $64.83 and $67.36 per share (overall weighted-average ≈ $65.59). Sales by date: Apr 23 — 42,642 shares ($2.79M); Apr 24 — 30,178 shares ($1.98M); Apr 27 — 2,180 shares (~$0.14M).
• These were outright sales (S = sale). Sales are often routine and do not by themselves indicate insider sentiment.

Key Details

• Transaction dates: April 23, 24 and 27, 2026. Report filed Apr 27, 2026 covering those trades.
• Total shares sold: 75,000; total proceeds: ~$4.92 million; overall weighted-average price ≈ $65.59/share.
• Footnotes: filing indicates at least some sales were effected under a Rule 10b5-1 trading plan. Several transactions were executed in multiple trades and reported as weighted averages with per-price details available on request. One footnote notes shares are held by Sariel Group Ltd., and the reporting person disclaims beneficial ownership of those shares except for any pecuniary interest.
• Shares owned after transaction: not specified in the provided excerpt—see the full Form 4 for post-transaction holdings.
• Timeliness: filing date Apr 27, 2026 is shown; Form 4s are generally due within two business days of a transaction—review the full filing for any late-filed flag.

Context

• Sales by insiders can be for many reasons (diversification, liquidity, planned dispositions). Purchases typically draw more attention as potential bullish signals; these were sales, some under a pre-set 10b5-1 plan which is a commonly used mechanism for pre-scheduled insider selling.
• The filing discloses weighted-average prices and offers to provide per-trade price details to the SEC, issuer, or security holders if requested. For full context, check the complete Form 4 on EDGAR.